Flex Pharma Completes Patient Enrollment in Phase 2 Trial of Muscle-relaxing Compound
News
Flex Pharma has completed enrolling multiple sclerosis patients in a Phase 2 clinical trial in Australia testing FLX-787’s ability to alleviate muscle stiffness, spasms, and cramps. ... Read more